Considering the omnipresence of BPA in urine and its impact as an endocrine disruptor through ERs and the AR, we hypothesized that BPA would impact the metabolism of healthy and cancer-associated bladder fibroblasts, which could promote bladder cancer progression. The gene discussed is AR; the disease is urinary bladder carcinoma.